Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

BS_893A91ZM

Neurofibroma

be14d8f0-087b-5859-8a8d-ac8a44ef59c6

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
Neurofibroma
cancer_type_detailed
subtype
cancer_type
Neurofibroma
overall_survival_months
198.850197109067
age_years
10.682
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.565
  • INTERFERON_GAMMA_RESPONSE+0.553
  • IL6_JAK_STAT3_SIGNALING+0.517
  • ALLOGRAFT_REJECTION+0.509
  • TNFA_SIGNALING_VIA_NFKB+0.477
  • INFLAMMATORY_RESPONSE+0.473
  • COMPLEMENT+0.381
  • APOPTOSIS+0.379
  • COAGULATION+0.378
  • IL2_STAT5_SIGNALING+0.368

Top 10 suppressed

  • E2F_TARGETS-0.371
  • PANCREAS_BETA_CELLS-0.362
  • G2M_CHECKPOINT-0.316
  • SPERMATOGENESIS-0.303
  • PROTEIN_SECRETION-0.255
  • MTORC1_SIGNALING-0.236
  • MYC_TARGETS_V1-0.214
  • FATTY_ACID_METABOLISM-0.187
  • OXIDATIVE_PHOSPHORYLATION-0.178
  • HEDGEHOG_SIGNALING-0.144

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

5 twins match this tumor's tissue · 5 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1BS_2W3NC4K1
brain-umap@2
Neurofibroma0.976
2BS_3Y0QXZQB
brain-umap@2
Neurofibroma0.951
3BS_0RF0EZTV
brain-umap@2
Neurofibroma0.930
4BS_NDRDM2A9
brain-umap@2
Neurofibroma0.915
5BS_B7QS4DHK
brain-umap@2
Schwannoma0.913
6BS_Y3G1X98S
brain-umap@2
Meningioma0.911
7BS_RQSKD7PN
brain-umap@2
MPNST0.910
8BS_GDHH6T5A
brain-umap@2
Neurofibroma0.903
9BS_Q2T9ZRM0
brain-umap@2
Meningioma0.894
10BS_KXMYBQ6N
medullo-epn-umap@date-based
EPNEPN Tumor0.892